|Podcasts|July 22, 2021
Episode 87: Attacking Bladder Cancer From All Sides
Author(s)Elaine Quilici
Arthur Kuan, CEO of CG Oncology, talks about the present and future of bladder cancer therapies, and how he’s committed to making a difference.
Advertisement
Arthur Kuan, CEO of CG Oncology, discusses bladder cancer therapies and how his company is contributing to the fight.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Your Phase III Clinical Protocol Is Your Initial Product Launch
2
AstraZeneca Enters $4.7 Billion Collaboration Agreement with CSPC Pharmaceuticals
3
Taking Advantage of ‘Hidden Gem’ Talent Hubs
4
Pharmaceutical Executive Daily: Public Citizen Sues The Trump Administration Over Undisclosed Drug Price Agreements
5